2023 Another Step Toward Trust: Our MDD Certification

In 2023, we reached a significant milestone that is not only a result of our work but also an expression of our attitude: Inspital's Class I products received approval according to the Medical Device Directive (MDD).

What may appear at first glance to be a purely regulatory achievement means something much deeper to us. Because anyone working in medical technology knows: certification means responsibility. It means thinking through every process, testing every component, examining every procedure with a view to the bigger picture—the safety and trust of medical professionals and patients worldwide.

This recognition was the result of years of work on our internal quality system, on our documentation, on the consistent implementation of our high standards—day by day, product by product. And it was proof that we don't just develop what is technically possible, but what makes sense medically and humanly.

With MDD certification, new doors opened: to more international partnerships, to expanded markets—and above all, to growing trust in the Inspital brand.

But for us, this step was not a conclusion, but a beginning. Because when it comes to quality, we know no finish line—only constant progress.

2023 was the year our quality commitment was officially confirmed.
And that obligates us—with every further step we take.

Academy

Here, everything revolves around knowledge and continuing education.

News Press

Here you will find current news about trade fairs, congresses, PR and other relevant topics.